Similar Items: Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics
- Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype
- Switching on p53: an essential role for protein phosphorylation?
- Modulation of immune responses by the tumor suppressor p53
- Evolution of Conformational Disorder & Diversity of the P53 Interactome
- Distinct target genes and effector processes appear to be critical for p53-activated responses to acute DNA damage versus p53-mediated tumour suppression
- Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases